Literature DB >> 8341056

Prognostic value of the number of metastatic lymph nodes in gastric cancer with radical surgery.

H Isozaki1, K Okajima, Y Kawashima, S Yamada, E Nakata, J Nishimura, T Ichinona.   

Abstract

To evaluate the effectiveness of extended lymph node dissection in gastric cancer, the relationship between the number of lymph nodes with metastasis and the long-term outcome was studied retrospectively in 761 patients who underwent curative resection with extensive lymph node dissection. The cumulative 5-year survival rate was 85.8% in patients without lymph node metastasis, 60.2% in those with 1-4 lymph nodes, 35.6% with 5-10 nodes, and 12.3% with 11 or more nodes involved. Concerning N2 or N3 patients in whom metastatic lymph nodes would have remained without extensive dissection, the 5-year survival rate was 70.5% in those with 1-4 lymph nodes involved and 44.0% with 5 or more lymph nodes involved when no serosal invasion was observed. It was 38.5% with 1-4 lymph nodes and 5% with 5 or more lymph nodes involved when serosal invasion was observed. These results suggest that extensive lymph node dissection is effective in gastric cancer patients without serosal invasion and, when only a few lymph nodes are involved, also in those with serosal invasion. However, it is not considered to be effective in patients with serosal invasion and metastasis to many lymph nodes. Combination therapies are thought to be required in such patients.

Entities:  

Mesh:

Year:  1993        PMID: 8341056     DOI: 10.1002/jso.2930530412

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

1.  Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients.

Authors:  M S Karpeh; L Leon; D Klimstra; M F Brennan
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

Review 2.  On the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancer.

Authors:  Roman Yarema; Giovanni de Manzoni; Taras Fetsych; Myron Ohorchak; Mykhailo Pliatsko; Maria Bencivenga
Journal:  World J Gastrointest Oncol       Date:  2016-06-15

Review 3.  Extended lymphadenectomy in gastric cancer: when, for whom and why.

Authors:  D H Roukos
Journal:  Ann R Coll Surg Engl       Date:  1998-01       Impact factor: 1.891

4.  VEGF, Flt-1, and microvessel density in primary tumors as predictive factors of colorectal cancer prognosis.

Authors:  Justyna Zygoń; Mariusz Szajewski; Wiesław Janusz Kruszewski; Robert Rzepko
Journal:  Mol Clin Oncol       Date:  2016-12-30

5.  Impact of lymph node metastasis on survival with early gastric cancer.

Authors:  Y Seto; H Nagawa; T Muto
Journal:  World J Surg       Date:  1997-02       Impact factor: 3.352

Review 6.  Extended lymph node dissection (D2 resection) should now be performed routinely in the curative surgical treatment of gastric carcinoma.

Authors:  D Ravichandran; M Lamah; N J Carty; C D Johnson
Journal:  Ann R Coll Surg Engl       Date:  1995-11       Impact factor: 1.891

Review 7.  Changing Trends in Gastric Cancer Surgery.

Authors:  İlter Özer; Erdal Birol Bostancı; Murat Ulaş; Yusuf Özoğul; Musa Akoğlu
Journal:  Balkan Med J       Date:  2017-01-05       Impact factor: 2.021

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.